Break in New Shoes One Step at a Time

Article

I advise patients with diabetic neuropathy to break in new shoes gradually.

I advise patients with diabetic neuropathy to break in new shoes gradually. I suggest that they wear them a maximum of 1 hour the first day, 2 hours the second day, 3 hours the third day, and so on up to a whole day. In this way, there is more time for the shoes to gradually adapt to the shape of the patient’s feet, thereby reducing the risk of potentially dangerous ulcerations.

-Fabrizio Losurdo, MD
    Bari, Italy

 

More Pointers >>

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Novel Non-Invasive Glucose Monitor Uses Light-Based Technology / image credit RSP Systems

Novel Non-Invasive Glucose Monitor Uses Light-Based Technology

Todd Shryock
April 11th 2025
Article

Accuracy of data recorded with the GlucoBeam was found to be comparable to standard finger-stick blood glucose tests.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Omnipod 5 System Leads to Significant Glycemic Improvements After Direct Transition from MDI Insulin Plus CGM

Omnipod 5 System Leads to Significant Glycemic Improvements After Direct Transition from MDI Insulin with CGM

Grace Halsey
March 27th 2025
Article

Mean reduction in HbA1c was nearly 1% after transition from MDI plus CGM to Omnipod 5 in the first randomized trial to evaluate the shift in mode of insulin delivery.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Sydney Jennings
July 22nd 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

Cost of Semaglutide, Tirzepatide Prohibitive Despite Significant Benefits

Cost of Semaglutide, Tirzepatide Prohibitive Despite Significant Benefits

Grace Halsey
March 14th 2025
Article

A new economic evaluation estimates that semaglutide would need to drop its current price by 81.9% and tirzepatide by 30.5% to be cost effective.

Bionic Pancreas for Type 1 Diabetes Found Feasible to Implement in Primary Care

Bionic Pancreas for Type 1 Diabetes Found Feasible to Implement in Primary Care

Sydney Jennings
March 14th 2025
Article

The iLet bionic pancreas system conferred an average glucose of less than 183 mg/dL in 97% of adults with T1D in a small study.

© 2025 MJH Life Sciences

All rights reserved.